Contributed Abstracts
Hall 1 (Salt Palace Convention Center)
Safety, Efficacy, and Favorability of Utilizing Levetiracetam for Busulfan-Induced Seizure Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplant (HCT)
Mara Bailey-Olson, MS, CPNP, UCSF Benioff Children's Hospital;
Janel Long-Boyle, PharmD, PhD, UCSF Benioff Children's Hospital;
Biljana Horn, MD, UCSF Benioff Children's Hospital;
Morton J Cowan, MD, UCSF Benioff Children's Hospital;
Justin T Wahlstrom, M.D., UCSF Benioff Children's Hospital;
Christopher C Dvorak, MD, UCSF Benioff Children's Hospital
Assessment of Brain Natriuretic Peptide in Patients Undergoing Hematopoietic Stem Cell Transplantation
Rajinder Bajwa, MBBS, MRCP, MD, Nationwide Children's;
Jennifer McArthur, DO, Medical College of Wisconsin;
Julie-An Talano, MD, Children's Hospital of Wisconsin;
Julie Fitzgerald, MD, Children's Hospital of Pittsburgh;
Christine Duncan, MD, Dana-Farber Cancer Institute;
Steven Margossian, MD PhD, Dana Farber Cancer Instituite/Children's Hospital Boston;
Andrew Yates, MD, Nationwide Children's Hospital;
Mark Hall, MD, Nationwide Children's Hospital;
Susan Cunnigham, Nationwide Children's Hospital;
Debbie Spear, Hershey Medical Center, Penn State Univeristy;
Katherine Luther, BS, Medical College of Wisconsin;
Robert Tamburro, MD, Hershey Medical Center, Penn State University
Prompt Treatment of Respiratory Syncytial Virus with Inhaled Ribavirin and IVIG in High Risk Allogeneic Stem Cell Transplant Recipients Significantly Diminishes Mortality
Patrick Bourgouin, BSc, Hematology/Stem Cell Transplantation, Maisonneuve Rosemont / University of Montreal, Montreal, QC, Canada;
Elizabeth Florence Krakow, MD, CM, FRCPC, Hematology/Stem Cell Transplantation, Maisonneuve Rosemont / University of Montreal, Montreal, QC, Canada;
Jean Roy, MD, FRCPC, Hematology/Stem Cell Transplantation, Maisonneuve Rosemont / University of Montreal, Montreal, QC, Canada;
Imran Ahmad, MD, Hematology/Stem Cell Transplantation, Maisonneuve Rosemont / University of Montreal, Montreal, QC, Canada;
Lea Bernard, MD, FRCPC, Hematology/Stem Cell Transplantation, Maisonneuve Rosemont / University of Montreal, Montreal, QC, Canada;
Jean-Sebastien Delisle, MD, PhD, FRCPC, Hematology/Stem Cell Transplantation, Maisonneuve Rosemont / University of Montreal, Montreal, QC, Canada;
Thomas Kiss, MD, FRCPC, Hematology/Stem Cell Transplantation, Maisonneuve Rosemont / University of Montreal, Montreal, QC, Canada;
Silvy Lachance, MD, FRCPC, Hematology/Stem Cell Transplantation, Maisonneuve Rosemont / University of Montreal, Montreal, QC, Canada;
Denis-Claude Roy, MD, FRCPC, Hematology/Stem Cell Transplantation, Maisonneuve Rosemont / University of Montreal, Montreal, QC, Canada;
Guy Sauvageau, MD, PhD, FRCPC, Hematology/Stem Cell Transplantation, Maisonneuve Rosemont / University of Montreal, Montreal, QC, Canada;
Sandra Cohen, MD, FRCPC, Maisonneuve Rosemont / University of Montreal
Incidence of Post-Transplant Bacterial Foodborne Pathogens in Hematopoietic Stem Cell Transplant Patients
Nicole Boyle, Fred Hutchinson Cancer Research Center;
Sara Podczervinski, RN, MPH, CIC, Seattle Cancer Care Alliance;
Kim Jordan, RD, CD, CNSD, Seattle Cancer Care Alliance;
Zach Stednick, MPH, Fred Hutchinson Cancer Research Center;
Susan Butler-Wu, PhD, University of Washington;
Kerry McMillen, MS, RD, CSO, Seattle Cancer Care Alliance;
Steven A. Pergam, MD, MPH, Fred Hutchinson Cancer Research Center
Tolerability of Daily Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation for Non-Malignant Disorders
David Buchbinder, MD, Children's Hospital of Orange County;
Steven M Neudorf, MD, Children's Hospital of Orange County;
Felice Adler, MD, Children's Hospital of Orange County;
Negar Ashouri, MD, Children's Hospital of Orange County;
Carla Daum, RN, CPON, Children's Hospital of Orange County;
Loan Hsieh, MD, Children's Hospital of Orange County;
Van Huynh, MD, Children's Hospital of Orange County;
Ivan Kirov, MD, Children's Hospital of Orange County;
Edna Klinger, RN, BS, Children's Hospital of Orange County;
Nancy Kuntz, RN, PNP, Children's Hospital of Orange County;
Delma Nieves, MD, Children's Hospital of Orange County;
Diane Jean Nugent, MD, Children's Hospital of Orange County;
Geetha Puthenveetil, MD, Children's Hospital of Orange County;
Elyssa Rubin, MD, Children's Hospital of Orange County;
Leonard Sender, MD, UC Irvine Medical Center;
Jasjit Singh, MD, Children's Hospital of Orange County;
Amit Soni, MD, Children's Hospital of Orange County;
Jill Stites, FNP, Children's Hospital of Orange County;
Lilibeth Torno, MD, Children's Hospital of Orange County;
Antonio Arrieta, MD, Children's Hospital of Orange County
Alternate Day Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT)
Sharat Chandra, MD, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, Cincinnati Children's Hospital Medical Center;
Alexandra Filipovich, MD, Cincinnati Children's Hospital Medical Center;
Jack Bleesing, MD, PhD, Cincinnati Children's Hospital Medical Center;
Michael Grimley, MD, Cincinnati Children's Hospital Medical Center;
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center;
Michael Jordan, MD, Cincinnati Children's Hospital Medical Center;
Ashish Kumar, MD, PhD, Cincinnati Children's Hospital Medical Center;
Rebecca A Marsh, MD, Cincinnati Children's Hospital Medical Center;
Kasiani Myers, MD, Cincinnati Children's Hospital Medical Center;
Richard Tarin, Cincinnati Children's Hospital Medical Center;
Stephanie Edwards, RN, BSN, Cincinnati Children's Hospital Medical Center;
Parinda A Mehta, MD, Cincinnati Children's Hospital Medical Center
Changing Trends in the Use of Surgical Biopsy for Diagnosis of Pulmonary Disease in Hematopoietic Cell Transplant Recipients
Guang-Shing Cheng, MD, University of Washington;
Zach Stednick, MPH, Fred Hutchinson Cancer Research Center;
David K. Madtes, MD, University of Washington;
George B. McDonald, MD, University of Washington;
Michael J. Boeckh, MD, University of Washington;
Steven A. Pergam, MD, MPH, Fred Hutchinson Cancer Research Center
A Single Daily Ultra Low-Dose of Oral Acyclovir Is Sufficient to Prevent the Occurrence of Herpes Zoster Post Hematopoietic Stem Cell Transplantation: Interim Results of a Prospective Randomized Trial
David Dennison, MBBS, MD, Sultan Qaboos University Hospital;
Iman Maktoom Al Manthari, BSc (Nursing), Sultan Qaboos University Hospital;
Murtadha Al-Khabori, MD, MSc, FRCPC, Sultan Qaboos University Hospital;
Revathi Raj, MRCPATH, Apollo Hopsitals, Chennai;
Sharat Damodar, MD, Narayana Hrudayalaya Hospital;
Alok Srivastava, MD, Christian Medical College;
Khalil Al Farsi, MD, FRCPC, Sultan Qaboos University Hospital;
Mohammed Al Huneini, MD, Sultan Qaboos University Hospital;
Abdulhakeem Rawas, MD, Sultan Qaboos University Hospital;
Yusra Al Habsi, BSc (Nursing), Sultan Qaboos University Hospital;
Arwa Z Al Riyami, MD, FRCPC, Sultan Qaboos University Hospital;
Aqeela Al Lawati, MSc (Pharmacy), Sultan Qaboos University Hospital;
Intisar Al Riyami, BSc (Pharmacy), Sultan Qaboos University Hospital;
Abdulla Balkhair, MD, Sultan Qaboos University Hospital;
Zahra Al Harthy, BSc (Nursing), Sultan Qaboos University Hospital;
Shyam Sundar Ganguly, MD, Sultan Qaboos Unversity;
Salam Al Kindi, MD, Sultan Qaboos University Hospital
Low Dose Liposomal Amphotericin B Followed by Micafungin Prophylaxis of Invasive Fungal Infections (IFI) in Pediatric Allogeneic Stem Cell Transplantation Recipients
Mona Elmacken, MD, New York Medical College;
Christopher Ours, New York Medical College;
Daniel Mitchell, BS, New York Medical College;
Olga Militano, PharmD, New York Medical College;
Carmella van de Ven, MS, New York Medical College;
Mitchell S. Cairo, MD, New York Medical College
Music Therapy for the Hematopoietic Stem Cell Transplant Patients
Joylyn Mae Estrella, RN, BSN, OCN, The University of Texas MD Anderson Cancer Center;
Buenagracia Dela Cruz, RN, MBA, OCN, M.D. Anderson Cancer Center;
Roxann Blackburn, RN, BSN, OCN, UT MD Anerson Cancer Center;
Joaquin A Buitrago, RN, MSN, OCN, MD Anderson Cancer Center;
Ingrid Moeller, MT, MD Anderson Cancer Center
Phototoxic Dermatoses in Pediatric BMT Patients Receiving Voriconazole
Rakesh K Goyal, MD, Children's Hospital of Pittsburgh of UPMC;
Robin P Gehris, MD, University of Pittsburgh Department of Dermatology;
Denise Howrie, PharmD, Children’s Hospital of Pittsburgh of UPMC;
Kayla M Cogley, PA, Children’s Hospital of Pittsburgh of UPMC;
Randy Windreich, MD, Children's Hospital of Pittsburgh of UPMC;
Raman Venkataramanan, PhD, University of Pittsburgh School of Pharmacy
Stress Testing Prior to Allogeneic Hematopoietic Stem Cell Transplantation
Anthony Pham, BS, Weill Cornell University Medical College;
Daniel Amoruso, MD, New York Presbyterian-Cornell;
Susanna Nguy, City College of New York;
Elizabeth E. Stillwell, PhD, Memorial Sloan-Kettering Cancer Center;
Jeffrey D. Wessler, MD, New York Presbyterian-Columbia;
Brian J Rebolledo, MD, Hospital for Special Surgery;
Richard M. Steingart, MD, Memorial Sloan-Kettering Cancer Center;
Ann A. Jakubowski, PhD MD, Memorial Sloan-Kettering Cancer Center;
Wendy L Schaffer, MD, PhD, Memorial Sloan-Kettering Cancer Center
Population Pharmacokinetic Study of a Test Dose Busulfan Patients Undergoing Hematopoietic Stem Cell Transplantation
Iracema Esteves Nogueira, MD, UNIFESP (Universidade Federal de São Paulo);
Juliana Fernandes, Instituto da Criança - HC - FMUSP;
Eduardo K Sugawara, RPh, Hospital Israelita Albert Einstein;
Jose Salvador de Oliveira, MD, PhD, UNIFESP (Universidade Federal de Sao Paulo);
Roseane Gouveia, MD, Instituto de Oncologia Pediatrica;
Morgani Rodrigues, Hospital Israelita Albert Einstein;
Daniele Porto Barros, RN, Instituto de Oncologia Pediátrica;
Mariane Pereira Diniz, PharmD, Instituto de Oncologia Pediátrica;
Fabio P. de Souza Santos, MD, Hospital Israelita Albert Einstein;
Andreza Feitosa Ribeiro, PhD, Hospital Israelita Albert Einstein;
Jairo J. N. Sobrinho, MD, Hospital Israelita Albert Einstein;
Sandra Saemi Nakashima, RPh, Hospital Israelita Albert Einstein;
Marcos de Lima, MD, Case Western Reserve University;
Nelson Hamerschlak, MD, PhD, Hospital Israelita Albert Einstein;
Fabio R. Kerbauy, MD, UNIFESP (Universidade Federal de Sao Paulo)
Catheter-Related Complications in Acute Myeloid Leukemia Patients After Hematopoietic Stem Cell Transplant
Mohammad O. Khalil, MD, Department of Internal Medicine, Section of Hematology and Oncology, University of Oklahoma Health Sciences Center;
Namali Pierson, MD, Department of Internal Medicine, University of Oklahoma Health Sciences Center;
George Selby, M.D., Department of Internal Medicine, Section of Hematology and Oncology, University of Oklahoma Health Sciences Center;
Mohamad Cherry, MD, Department of Internal Medicine, Section of Hematology and Oncology, University of Oklahoma Health Sciences Center;
Jennifer Holter, MD, Department of Internal Medicine, Section of Hematology and Oncology, University of Oklahoma Health Sciences Center
Development of a Consistent Approach to the Management Chemo/Radiation Induced Dermatitis in Children Undergoing Allogeneic Stem Cell Transplantation
Nancy Kuntz, RN, PNP, Children's Hospital of Orange County;
Carla Daum, RN, CPON, Children's Hospital of Orange County;
Ivan Kirov, MD, Children's Hospital of Orange County;
Steven Neudorf, MD, Children's Hospital of Orange County;
Leonard Sender, MD, UC Irvine Medical Center
Incidence and Outcomes of Fungal Infections in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Eight Years Single Center Experience
Gregory Wallace, DO, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, Cincinnati Children's Hospital Medical Center;
Alexandra Filipovich, MD, Cincinnati Children's Hospital Medical Center;
Beverly Connelly, MD, Cincinnati Children's Hospital Medical Center;
Michael Cloughessy, Cincinnati Children's Hospital Medical Center;
Jack Bleesing, MD, PhD, Cincinnati Children's Hospital Medical Center;
Sharat Chandra, MD, Cincinnati Children's Hospital Medical Center;
Michael Grimley, MD, Cincinnati Children's Hospital Medical Center;
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center;
Michael Jordan, MD, Cincinnati Children's Hospital Medical Center;
Ashish Kumar, MD, PhD, Cincinnati Children's Hospital Medical Center;
Rebecca A Marsh, MD, Cincinnati Children's Hospital Medical Center;
Kasiani Myers, MD, Cincinnati Children's Hospital Medical Center;
Denise Bellman, Cincinnati Children's Hospital Medical Center;
Parinda A Mehta, MD, Cincinnati Children's Hospital Medical Center
Incidence of Pneumocystis Jirovecii Infection and Duration of Prophylaxis After Allogeneic Stem Cell Transplantation
Asmita Mishra, MD, H. Lee Moffitt Cancer Center;
Julio C Chavez, H. Lee Moffitt Cancer Center;
Marcie Tomblyn, MD, MS, H. Lee Moffitt Cancer Center;
Claudio Anasetti, MD, H. Lee Moffitt Cancer Center;
Ernesto Ayala, H. Lee Moffitt Cancer Center;
Teresa Field, MD PhD, H. Lee Moffitt Cancer Center;
Mohamed Kharfan-Dabaja, H. Lee Moffitt Cancer Center;
Lia Elena Perez, M.D., H. Lee Moffitt Cancer Center;
Hugo Fernandez, H. Lee Moffitt Cancer Center
Safety of Coadministaraion of Teicoplanin and Tacrolimus After Allogeneic Hematopoietic Stem Cell Transplantation
Takehiko Mori, MD, PhD, Keio University School of Medicine;
Jun Kato, MD, Keio University School of Medicine;
Akiko Yamane, MD, PhD, Keio University School of Medicine;
Sumiko Kohashi, MD, Keio University School of Medicine;
Shinichiro Okamoto, MD, PhD, Keio University School of Medicine
A Restrictive Red Cell Transfusion Approach Does Not Adversely Affect Day 100 or 1 Year Survival in Multiple Myeloma Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation
Neha R Patil, University of Alabama at Birmingham;
Marisa Marques, University of Alabama at Birmingham;
Shin Mineishi, M.D., University of Michigan;
Sandra Rudolph, RN, MSN, University of Alabama at Birmingham;
William Vaughan, MD, University of Alabama in Birmingham;
Racquel Innis-Shelton, MD, University of Alabama at Birmingham;
Donna Salzman, MD, The University of Alabama at Birmingham
Microbiology in Patients Undergoing Stem Cell Transplantation in the First Year of a Tertiary Care Comprehensive Cancer Centre From India
Vivek S Radhakrishnan, MD DM MSc PDF(BMT), Tata Medical Center (TMC);
Mammen Chandy, MD FRCP FRACP FRCPA, Tata Medical Center;
Sanjay Bhattacharya, MD DNB DipRCPath FRCPath CCT (UK), TMC;
Saurabh Jayant Bhave, MD, TMC;
Anupam Chakrapani, MD DM, TMC
Oral Glutamine and Probiotics On Enteral Morbidity Following Autologous Stem Cell Transplantation for Plasma Cell Dyscrasias
Anne S. Renteria, MD, Mount Sinai Medical Center;
Rita M. Jakubowski, MSN, RN, OCN-ANP-BC, Mount Sinai Medical Center;
Alexandra Rothwell, RD, CSO, CDN, Mount Sinai Medical Center;
Carroll Hayek, Mount Sinai Medical Center;
Keren Osman, MD, Mount Sinai Medical Center;
Adriana K. Malone, MD, Mount Sinai Medical Center;
Sundar Jagannath, MD, Mount Sinai Medical Center;
Luis Isola, MD, Mount Sinai Medical Center;
Ajai Chari, MD, Mount Sinai Medical Center
Immunogenecity of Early Post Transplant Vaccination in Children
Micah Skeens, RN MS PNP, Nationwide Childrens;
Monica Ardura, MD, Nationwide Children's;
Rajinder Bajwa, MBBS, MRCP, MD, Nationwide Children's;
Thomas G. Gross, MD, PhD, Nationwide Children's Hospital;
Kristen Mccrea, RN, Nationwide Children's Hospital;
Sandeep Soni, MBBS, MD, Nationwide Children's Hospital
Changing Epidemiology of Infections in Children and Adolescents After Autologous and Allogeneic Hematopoietic Stem Cell Transplantation
Ashok Srinivasan, MD, St.Jude Children's Research Hospital;
Laura McLaughlin, BS, Florida State University College of Medicine;
Chong Wang, BS, St Jude Children's Research Hospital;
Deo K Srivastava, PhD, St Jude Children's Research Hospital;
David Shook, MD, St. Jude Children's Research Hospital;
Wing Leung, MD, PhD, St. Jude Children's Research Hospital;
Randall T Hayden, MD, St. Jude Children's Research Hospital
Pretransplant Psychiatric Evaluations - a Survey of NMDP Programs
Amir Steinberg, MD, Mount Sinai Hospital;
Imelda De la Vega-Diaz, Mount Sinai Hospital;
Ina Florez, Mount Sinai Hospital;
Elaine Gorman, Mount Sinai Hospital;
Carroll Hayek, Mount Sinai Medical Center;
Phyllis Kaskel, Mount Sinai Hospital;
Sara Kim, PharmD, BCOP, The Mount Sinai Medical Center;
Ayelet Nelson, Mount Sinai Hospital;
Monank Patel, Mount Sinai Hospital;
Ginny Ross, Mt. Sinai Medical Center;
Alex Rothwell, Mount Sinai Hospital;
Patricia Saunders, Mount Sinai Hospital;
Sharon Tindle, Mount Sinai Hospital;
Luis Isola, MD, Mount Sinai Medical Center
Surgical Mask Usage Reduces the Incidence of Parainfleunza Virus 3 in Recipients of Stem Cell Transplantation
Anthony D. Sung, M.D., Duke University Medical Center;
Julia A.M. Sung, M.D., Duke University Medical Center;
Kelly Corbet, Duke University Medical Center;
Vera Hars, M.S., Duke University Medical Center;
Lan Lan, Ph.D., Duke University Medical Center;
Gloria Broadwater, M.S., Duke University Medical Center;
Ashley Zanter, M.S.N., Duke University Medical Center;
John Chute, M.D., Duke University Medical Center;
Cristina Gasparetto, M.D., Duke University Medical Center;
Gwynn Long, M.D., Duke University Medical Center;
David Rizzieri, M.D., Duke University Medical Center;
Keith Sullivan, M.D., Duke University Medical Center;
Nelson J. Chao, MD, Duke University Medical Center;
Mitchell E. Horwitz, M.D., Duke University Medical Center
Is Edentulism Associated with Lower Bacteremia and Transplant-Associated Toxicities in Patients with Multiple Myeloma?
Juan J Toro, MD, MSCI, South Texas Veterans Health Care System;
Deanna Schneider, BSN, South Texas Veterans Health Care System;
Shuko Lee, BS, South Texas Veterans Health Care System;
Gregory M Smith, DDS, South Texas Veterans Health Care System;
Francisca Gushiken, MD, South Texas Veterans Health Care System;
David J Haile, MD, South Texas Veterans Health Care System;
Cesar O Freytes, MD, South Texas Veterans Health Care System
![[Visit Client Website]](images/banner.gif)